Villalba, M.; Exposito, F.; Pajares, M.J.; Sainz, C.; Redrado, M.; Remirez, A.; Wistuba, I.; Behrens, C.; Jantus-Lewintre, E.; Camps, C.;
et al. TMPRSS4: A Novel Tumor Prognostic Indicator for the Stratification of Stage IA Tumors and a Liquid Biopsy Biomarker for NSCLC Patients. J. Clin. Med. 2019, 8, 2134.
https://doi.org/10.3390/jcm8122134
AMA Style
Villalba M, Exposito F, Pajares MJ, Sainz C, Redrado M, Remirez A, Wistuba I, Behrens C, Jantus-Lewintre E, Camps C,
et al. TMPRSS4: A Novel Tumor Prognostic Indicator for the Stratification of Stage IA Tumors and a Liquid Biopsy Biomarker for NSCLC Patients. Journal of Clinical Medicine. 2019; 8(12):2134.
https://doi.org/10.3390/jcm8122134
Chicago/Turabian Style
Villalba, Maria, Francisco Exposito, Maria Jose Pajares, Cristina Sainz, Miriam Redrado, Ana Remirez, Ignacio Wistuba, Carmen Behrens, Eloisa Jantus-Lewintre, Carlos Camps,
and et al. 2019. "TMPRSS4: A Novel Tumor Prognostic Indicator for the Stratification of Stage IA Tumors and a Liquid Biopsy Biomarker for NSCLC Patients" Journal of Clinical Medicine 8, no. 12: 2134.
https://doi.org/10.3390/jcm8122134
APA Style
Villalba, M., Exposito, F., Pajares, M. J., Sainz, C., Redrado, M., Remirez, A., Wistuba, I., Behrens, C., Jantus-Lewintre, E., Camps, C., Montuenga, L. M., Pio, R., Lozano, M. D., de Andrea, C., & Calvo, A.
(2019). TMPRSS4: A Novel Tumor Prognostic Indicator for the Stratification of Stage IA Tumors and a Liquid Biopsy Biomarker for NSCLC Patients. Journal of Clinical Medicine, 8(12), 2134.
https://doi.org/10.3390/jcm8122134